BNTX

BioNTech SEC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

BNTX vs peer average

49/100

BNTX vs. peer average (C vs. C)

Grade spread

A 1 · B 3 · C 3 · D 4

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

GMAB is the first available peer comparator.

Genmab — oncology-focused biologics developer with late-stage cancer programs; useful comparator on program-readout sensitivity and partnership-driven upside.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerGMABGenmab A/S

BNTX

BioNTech SE

GMAB

Genmab A/S

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs GMAB

BNTX / GMAB

Grade Position

In line

BNTX vs. peer average (C vs. C)

49/100

Momentum

GMAB

Value

GMAB

Sentiment

BNTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs BNTX

GMAB

100/100

-2

GILD

60/100

Even

AMGN

40/100

INSM

Insmed Inc Common

80/100

-1

INCY

Incyte Corp Common

80/100

-1

GMAB is the first peer returned for this comparison set.